ANIK - Anika Therapeutics Inc Earnings

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: LFCR TKNO EBS OGI ACB EOLS PCRX HROW ANIP INDV

| Held by: VTI IWM VXF IWN SCHA DFSV VTWO DFMC DFAS IWC

Scroll to Statements

Index	RUT
Market Cap	290.28M
Enterprise Value	277.12M
Income	-3.78M
Sales	120.65M
Book/sh	10.26
Cash/sh	2.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	235
IPO	May 03, 1993

P/E	-
Forward P/E	29.51
PEG	0.25
P/S	2.41
P/B	2.11
P/C	7.56
P/FCF	518.35
EV/EBITDA	543.36
EV/Sales	2.30
Quick Ratio	3.19
Current Ratio	4.48
Debt/Eq	0.18
LT Debt/Eq	0.17
Option/Short	Yes / Yes

EPS (ttm)	-0.27
EPS next Y	0.73
EPS next Q	0.23
EPS this Y	381.82%
EPS next Y	38.68%
EPS next 5Y	118.66%
EPS past 3/5Y	9.40% 14.76%
Sales past 3/5Y	-10.28% -2.86%
EPS Y/Y TTM	93.57%
Sales Y/Y TTM	-2.50%
EPS Q/Q	187.26%
Sales Q/Q	15.56%
Earnings	Jul 29 BMO
EPS/Sales Surpr.	625.00% 11.62%

Insider Own	6.28%
Insider Trans	2.34%
Inst Own	91.78%
Inst Trans	-0.75%
ROA	-1.68%
ROE	-2.19%
ROIC	-2.36%
Gross Margin	62.16%
Oper. Margin	-4.24%
Profit Margin	-3.14%
SMA20	12.45%
SMA50	29.24%
SMA200	63.51%
Trades

Shs Outstand	13.38M
Shs Float	12.54M
Short Float	2.45%
Short Ratio	3.57
Short Interest	0.31M
52W High	22.88 -5.20%
52W Low	8.22 163.85%
Volatility	6.04% 6.39%
ATR (14)	1.11
RSI (14)	68.81
Beta	0.21
Rel Volume	1.19
Avg Volume	86.16K
Volume	12,077

Perf Week	-1.54%
Perf Month	43.07%
Perf Quarter	46.36%
Perf Half Y	106.18%
Perf YTD	125.70%
Perf Year	152.50%
Perf 3Y	15.31%
Perf 5Y	-47.63%
Perf 10Y	-56.46%
Recom	1.00
Target Price	21.00
Prev Close	21.57
Price	21.69
Change %	0.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)